Streetbeat News

Regulatory

TAK

The FDA has approved Takeda's GAMMAGARD LIQUID for adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). This approval is based on Phase 3 ADVANCE-CIDP study data, which demonstrated the safety and efficacy of GAMMAGARD LIQUID as an intravenous therapy. With this new indication, GAMMAGARD LIQUID becomes the only intravenous immune globulin (IVIG) approved for multiple neuromuscular disorder indications in the U.S.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 4:11 pm

BLK

BTCUSD

Harvest Fund has applied for the first Bitcoin spot ETF in Hong Kong, indicating growing acceptance of cryptocurrencies in financial markets. This follows the SEC's approval of Bitcoin spot ETFs in the U.S. The approval could attract more investors, including those from China, where the stock market underperformed in 2023. Anndy Lian suggests this could lead to more Chinese investment in crypto. The SFC aims to list the ETF on the Hong Kong Stock Exchange after the Chinese New Year, potentially allowing direct Bitcoin subscriptions.

Portfolio Pulse from Murtuza Merchant

January 29, 2024 | 4:03 pm

AMIX

Trading for the IPO security AMIX was halted but has now resumed as of 10:35 AM ET.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 3:35 pm

CRLBF

CURLF

GTBIF

Ohio lawmakers are working on rules for legal adult-use cannabis sales, with optimism for progress in the spring. The state's House Speaker and Senate President are aiming for legislative action following the legalization vote two months ago. Meanwhile, experts at Crain's Cleveland Business Cannabis Summit discussed the potential and challenges of the new market. Companies like Green Thumb Industries, Curaleaf Holdings, and Cresco Labs are preparing for the opportunity.

Portfolio Pulse from Jelena Martinovic

January 29, 2024 | 3:04 pm

PFE

The FDA has revised the Letter of Authorization for the Emergency Use Authorization (EUA) of Paxlovid, an oral antiviral treatment for COVID-19. This revision could potentially impact the use and distribution of Paxlovid, which is developed by Pfizer Inc. (PFE).

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:59 pm

COIN

A report from Coinbase Inc.'s advocacy group, Stand with Crypto, highlights a group of U.S. senators who are vocal supporters of cryptocurrency, indicating a shift in the political landscape. Senators Cynthia Lummis, Ted Burr, Ted Cruz, Bill Hagerty, and Marsha Blackburn have collectively introduced and supported various crypto-related bills and made numerous public statements advocating for the sector. In contrast, Senator Elizabeth Warren has introduced anti-crypto bills and made statements against digital currencies, showing a divided Senate on the issue of cryptocurrency.

Portfolio Pulse from Murtuza Merchant

January 29, 2024 | 2:56 pm

AGS

PlayAGS, Inc. has reported in an SEC filing that its preliminary total revenues for Q4 are expected to be between $92.5 million and $94.5 million.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:25 pm

PALI

Palisade Bio's stock price increased following their request to withdraw a recently filed registration statement. Additionally, the company presented positive preclinical data for PALI-2108, their lead program, at the 2024 Crohn's & Colitis Congress.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:19 pm

BABA

BIDU

EWH

JD

NIO

PDD

A Hong Kong court ordered the liquidation of China Evergrande Group, once China's largest real estate developer. The company's shares plummeted 21% before trading was suspended. CEO Shawn Siu expressed commitment to clients and continuity, planning to work with the liquidator, Alvarez & Marsal Inc. The market impact is mixed, with the Hang Seng Index closing higher and mainland Chinese shares dipping slightly. Chinese companies listed in New York showed varied premarket reactions, with Alibaba up 0.7% and PDD Holdings down 3.3%, while others like JD.com, NIO, and Baidu were mostly flat.

Portfolio Pulse from Piero Cingari

January 29, 2024 | 2:18 pm

MULN

Mullen Automotive has announced that its Class 3 electric vehicle (EV) truck, the Mullen THREE, has received certification from the California Air Resources Board (CARB) and is now ready for sale in all CARB states and the District of Columbia.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:17 pm